Media

Media Contacts

Corporate Communications
Australia and New Zealand
auabbviecorporatecomms@abbvie.com

2024

14th of November

Allergan Aesthetics welcomes the inclusion of  SKINVIVE^® by JUVÉDERM^® (hyaluronic acid injectable gel) on the Australian Register of Therapeutic Goods (ARTG) for the treatment of fine lines and for improving skin quality attributes such as hydration and elasticity.

Contact Corporate Communications for a copy of this media release.

Great People. Great Products. Greater Opportunity.

Allergan Aesthetics is an AbbVie (NYSE: ABBV) company that develops, manufactures and markets a portfolio of leading aesthetics brands and products for consumers around the world. 

The Allergan Aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more.
 
With its own research and development team focused on driving innovation in aesthetics, Allergan Aesthetics  is committed to providing the most comprehensive science-based product offerings available.

Carrie Strom

Senior Vice President AbbVie, and President, Global Allergan Aesthetics

Carrie Strom is Senior Vice President AbbVie, and President Global Allergan Aesthetics and has served in this role since May 2020.

Read Full Biography